✦ LIBER ✦

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Lee, Jae Jin; Maeng, Chi Hoon; Baek, Seon Kyung; Kim, Gou Young; Yoo, Jee-Hong; Choi, Cheon Woong; Kim, Yee Hyung; Kwak, Young-Tae; Kim, Dae-Hyun; Lee, Young Kyung; Kim, Jung Bo; Kim, Si-Young

Book ID: 119320352
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 301 KB
Volume: 70
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2010.02.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined analysis of intratumoral human

Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection

✍ Nakagawa, Naoya; Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 842 KB